绿叶制药(02186)今日盘中大涨5.17%，引起了市场的关注。
消息面上，公司此前公布了2025年业绩。数据显示，2025年公司股东应占溢利同比增长31.12%，达到约6.19亿元，每股基本盈利为15.88分。
公告称，公司收入同比增长4.1%至63.08亿元，收入增长主要归因于若干产品的销售及授权许可收入增加。这份强劲的业绩报告提振了投资者信心，推动了股价在交易时段内的显著上涨。
绿叶制药(02186)今日盘中大涨5.17%，引起了市场的关注。
消息面上，公司此前公布了2025年业绩。数据显示，2025年公司股东应占溢利同比增长31.12%，达到约6.19亿元，每股基本盈利为15.88分。
公告称，公司收入同比增长4.1%至63.08亿元，收入增长主要归因于若干产品的销售及授权许可收入增加。这份强劲的业绩报告提振了投资者信心，推动了股价在交易时段内的显著上涨。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.